Experience the New Standard in AI Remote Cardiac Monitoring
The leading AI-powered platform increases staff productivity by up to 84%1.
* SignalHF is an FDA-cleared Class II medical device, see the instructions for use for more information.
SignalHF*, the FDA-cleared AI algorithm that predicts HF hospitalizations
Our Solutions
A universal, alert-based platform for remote cardiac monitoring and research.
Electrophysiologist-designed AI-driven solutions that enable effective remote patient monitoring and medical research innovation.
CIED Remote Monitoring
HF Remote Monitoring
Advanced Research Tool
Unique Features and Core Capabilities
ILR ECG Analyzer²
Utilize AI to reduce the number of false positives by 79% when analyzing ECG recordings from patients implanted with Medtronic ILRs, while maintaining a sensitivity of 99%.3
Patient Connectivity Management
Reconnect 28%4 of patients two days after they disconnect, using automated SMS.
InLink
Streamline your In-Clinic data workflow.
AF Alert Management⁵
Detect clinically relevant events proven to lead to an 85% decrease in unnecessary AF alerts compared to alerts transmitted by a cardiac implantable electronic device (CIED).
Dynamic Billing Engine
Achieve 90%+ billing compliance6 with optimized scheduling and auto-generated reports.
1. Implicity data. Staff productivity increase after 2 years of using the Implicity platform, based on data from 56 medical centers. 2. FDA cleared Class II medical device and CE marked Class I (under MDD) medical device, see the instructions for use for more information. 3. Read Academic Group Article 6393406 4. Durand, Julien, et al., Using Technology to Improve Reconnection to Remote Monitoring in Cardiac Implantable Electronic Device Patients, Cardiovascular Digital Health Journal, Volume 0, Issue 0 Published: November 23, 2023 DOI. 5. IM009: 2021. Manufacturer: Implicity. IM009 is a software as a medical device (SaMD) intended to be used as an adjunct of a remote monitoring platform to follow up target population patients. Based notably on anticoagulant status of patients. 6. Jay Ganji, MD, FACC, Cardiologist, Piedmont Cardiovascular, November 2022. 6. Jay Ganji, MD, FACC, Cardiologist, Piedmont Cardiovascular, November 2022.
What our customers are saying
Jay Ganji, MD, FACC
Piedmont Cardiovascular, Greensboro, NC
“Love Implicity for “simplicity”. Easy to use, reliable CRM platform offering first-class support at our fingertips.”
Remote Monitoring of CIEDs has been the new standard of care since 2015
Recommendation 1A: HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices, 2015, Slotwiner & al.